PeptideDB

GSK251

CAS No.: 2125968-05-8

GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique bindi
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.
molecular weight 584.71
Molecular formula C29H37FN6O4S
CAS 2125968-05-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 50 mg/mL (85.5 mM), Sonication and heating to 60℃ are recommended.
References 1. Down K, et al. Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode. J Med Chem. 2021 Sep 23;64(18):13780-13792.